INSULIN ASPART

INSULIN ASPART was reported 63970 times

These side effects are most commonly reported by patients taking INSULIN ASPART:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 10783
1 NAUSEA 3979
2 DRUG INEFFECTIVE 3491
3 BLOOD GLUCOSE DECREASED 3443
4 FATIGUE 2794
5 DIARRHOEA 2707
6 DYSPNOEA 2680
7 VOMITING 2575
8 OFF LABEL USE 2201
9 DIZZINESS 2119
10 HEADACHE 1916
11 FALL 1905
12 WEIGHT DECREASED 1890
13 PAIN 1859
14 DEATH 1851
15 MALAISE 1847
16 ASTHENIA 1754
17 ACUTE KIDNEY INJURY 1753
18 HYPOGLYCAEMIA 1714
19 CHRONIC KIDNEY DISEASE 1641
20 PNEUMONIA 1620
21 RENAL FAILURE 1615
22 PRODUCT QUALITY ISSUE 1437
23 VISUAL IMPAIRMENT 1437
24 DECREASED APPETITE 1409
25 DIABETIC KETOACIDOSIS 1392
26 WEIGHT INCREASED 1373
27 CONSTIPATION 1365
28 PAIN IN EXTREMITY 1343
29 CONDITION AGGRAVATED 1273
30 GLYCOSYLATED HAEMOGLOBIN INCREASED 1255
31 ABDOMINAL PAIN 1250
32 CEREBROVASCULAR ACCIDENT 1201
33 PRURITUS 1183
34 INJECTION SITE PAIN 1178
35 ANXIETY 1142
36 DEHYDRATION 1117
37 ARTHRALGIA 1099
38 RASH 1092
39 DIABETES MELLITUS INADEQUATE CONTROL 1062
40 HYPERTENSION 1058
41 COUGH 1039
42 MYOCARDIAL INFARCTION 1020
43 FEELING ABNORMAL 1015
44 ANAEMIA 999
45 PYREXIA 999
46 ABDOMINAL PAIN UPPER 993
47 URINARY TRACT INFECTION 989
48 INCORRECT DOSE ADMINISTERED 985
49 DEPRESSION 968
50 CHEST PAIN 947
51 HYPERGLYCAEMIA 927
52 SEPSIS 913
53 BACK PAIN 909
54 INSOMNIA 895
55 SOMNOLENCE 892
56 PRODUCT DOSE OMISSION ISSUE 883
57 TREMOR 869
58 HOSPITALISATION 858
59 PERIPHERAL SWELLING 847
60 HYPERHIDROSIS 841
61 HYPOTENSION 837
62 BLOOD GLUCOSE FLUCTUATION 835
63 ABDOMINAL DISTENSION 829
64 DIABETES MELLITUS 826
65 END STAGE RENAL DISEASE 823
66 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 804
67 NEUROPATHY PERIPHERAL 792
68 GAIT DISTURBANCE 774
69 VISION BLURRED 771
70 DRUG DOSE OMISSION 764
71 CARDIAC FAILURE CONGESTIVE 760
72 LOSS OF CONSCIOUSNESS 756
73 MUSCLE SPASMS 742
74 OEDEMA PERIPHERAL 741
75 STRESS 739
76 CONFUSIONAL STATE 736
77 MEMORY IMPAIRMENT 708
78 BLOOD GLUCOSE ABNORMAL 663
79 DRUG HYPERSENSITIVITY 657
80 CATARACT 656
81 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 651
82 ABDOMINAL DISCOMFORT 625
83 COVID-19 615
84 BLOOD PRESSURE INCREASED 609
85 NASOPHARYNGITIS 594
86 THROMBOSIS 592
87 ATRIAL FIBRILLATION 585
88 GENERAL PHYSICAL HEALTH DETERIORATION 583
89 PRODUCT USE ISSUE 575
90 DEVICE MALFUNCTION 570
91 ASTHMA 554
92 INFECTION 525
93 PRODUCT STORAGE ERROR 519
94 CARDIAC DISORDER 514
95 IMPAIRED GASTRIC EMPTYING 513
96 SWELLING 513
97 HYPOAESTHESIA 511
98 BLINDNESS 505
99 GASTROOESOPHAGEAL REFLUX DISEASE 499
100 URTICARIA 497
101 INJECTION SITE HAEMORRHAGE 492
102 PULMONARY EMBOLISM 491
103 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 487
104 INTENTIONAL PRODUCT MISUSE 487
105 HYPERSENSITIVITY 485
106 PRODUCT USE IN UNAPPROVED INDICATION 479
107 DYSPEPSIA 477
108 HYPONATRAEMIA 476
109 DRUG INTERACTION 472
110 INFLUENZA 467
111 FLUID RETENTION 456
112 MUSCULAR WEAKNESS 456
113 GASTROINTESTINAL HAEMORRHAGE 455
114 MYALGIA 455
115 ARTHRITIS 449
116 DRY MOUTH 449
117 PALPITATIONS 444
118 ILLNESS 442
119 PANCREATITIS 440
120 CELLULITIS 436
121 BRONCHITIS 434
122 RENAL IMPAIRMENT 432
123 BLOOD CREATININE INCREASED 424
124 SLEEP DISORDER 413
125 CHEST DISCOMFORT 412
126 PARAESTHESIA 408
127 NEPHROGENIC ANAEMIA 407
128 SYNCOPE 404
129 RENAL INJURY 403
130 HYPOGLYCAEMIC UNCONSCIOUSNESS 402
131 DEVICE ISSUE 398
132 RENAL DISORDER 391
133 ALOPECIA 390
134 INJECTION SITE BRUISING 389
135 HAEMOGLOBIN DECREASED 386
136 ASCITES 377
137 WHEEZING 375
138 HYPOACUSIS 361
139 CONTUSION 360
140 BALANCE DISORDER 355
141 ERYTHEMA 355
142 DRUG INTOLERANCE 351
143 BLOOD CHOLESTEROL INCREASED 350
144 HEART RATE INCREASED 350
145 SINUSITIS 348
146 MULTIPLE ORGAN DYSFUNCTION SYNDROME 342
147 SEIZURE 339
148 PRODUCT DOSE OMISSION 334
149 CHILLS 333
150 DEVICE FAILURE 331
151 HAEMORRHAGE 330
152 PLEURAL EFFUSION 330
153 LUNG DISORDER 329
154 PRODUCTIVE COUGH 328
155 JOINT SWELLING 327
156 DIABETIC RETINOPATHY 324
157 CARDIAC FAILURE 314
158 HYPERKALAEMIA 313
159 RENAL FAILURE ACUTE 311
160 PLATELET COUNT DECREASED 307
161 DYSPHAGIA 305
162 UNDERDOSE 300
163 MUSCULOSKELETAL STIFFNESS 294
164 UNEVALUABLE EVENT 291
165 AMNESIA 289
166 LETHARGY 288
167 RESPIRATORY FAILURE 288
168 MATERNAL EXPOSURE DURING PREGNANCY 285
169 MIGRAINE 285
170 CARDIOGENIC SHOCK 284
171 INTENTIONAL PRODUCT USE ISSUE 284
172 UPPER RESPIRATORY TRACT INFECTION 284
173 FLATULENCE 281
174 HYPOXIA 281
175 TRANSIENT ISCHAEMIC ATTACK 279
176 TREATMENT NONCOMPLIANCE 279
177 VENTRICULAR FIBRILLATION 279
178 APPENDICITIS 277
179 OEDEMA 276
180 CORONARY ARTERY DISEASE 275
181 INJECTION SITE ERYTHEMA 273
182 CARDIAC ARREST 269
183 HAEMOPTYSIS 269
184 ASPARTATE AMINOTRANSFERASE INCREASED 267
185 DIABETIC NEUROPATHY 267
186 ROAD TRAFFIC ACCIDENT 267
187 GASTROINTESTINAL DISORDER 266
188 THROMBOCYTOPENIA 265
189 WRONG DRUG ADMINISTERED 265
190 OROPHARYNGEAL PAIN 263
191 BLOOD PRESSURE DECREASED 261
192 EPISTAXIS 261
193 PSORIASIS 260
194 APPENDICOLITH 257
195 SKIN ULCER 257
196 LOCALISED INFECTION 256
197 MEDICATION ERROR 255
198 NEURALGIA 255
199 SLEEP APNOEA SYNDROME 254
200 GOUT 252
201 OVERDOSE 252
202 NEOPLASM MALIGNANT 251
203 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 251
204 WHITE BLOOD CELL COUNT DECREASED 249
205 DYSGEUSIA 248
206 STAPHYLOCOCCAL INFECTION 248
207 HYPOTHYROIDISM 246
208 POLLAKIURIA 245
209 INJURY 244
210 PULMONARY OEDEMA 241
211 SURGERY 241
212 DYSPNOEA EXERTIONAL 238
213 CYSTITIS 235
214 HYPERLIPIDAEMIA 235
215 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 235
216 NASAL CONGESTION 233
217 BACTERIAL INFECTION 232
218 EXPIRED PRODUCT ADMINISTERED 232
219 EYE DISORDER 232
220 VISUAL ACUITY REDUCED 232
221 DRUG ADMINISTRATION ERROR 231
222 EMOTIONAL DISTRESS 230
223 BLOOD POTASSIUM DECREASED 229
224 DRY SKIN 229
225 RHINORRHOEA 229
226 HALLUCINATION 228
227 NERVOUSNESS 228
228 ILL-DEFINED DISORDER 227
229 INJECTION SITE MASS 227
230 OXYGEN SATURATION DECREASED 227
231 AGITATION 226
232 DISEASE PROGRESSION 226
233 FLUSHING 226
234 DEEP VEIN THROMBOSIS 223
235 DISABILITY 223
236 MENTAL STATUS CHANGES 222
237 BLADDER CANCER 221
238 BURNING SENSATION 221
239 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219
240 STOMATITIS 219
241 ALANINE AMINOTRANSFERASE INCREASED 217
242 BLISTER 217
243 LIMB INJURY 217
244 CHOLELITHIASIS 214
245 PULMONARY FIBROSIS 212
246 DEMENTIA 211
247 NEPHROLITHIASIS 211
248 TACHYCARDIA 211
249 FUNGAL INFECTION 210
250 OSTEOARTHRITIS 210
251 VERTIGO 210
252 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 209
253 EYE HAEMORRHAGE 208
254 HYPOKALAEMIA 208
255 BRADYCARDIA 206
256 INJECTION SITE PRURITUS 206
257 EYE PAIN 205
258 FEELING HOT 205
259 MOBILITY DECREASED 205
260 MUSCULOSKELETAL PAIN 205
261 MYASTHENIA GRAVIS 205
262 BLINDNESS UNILATERAL 204
263 FOETAL EXPOSURE DURING PREGNANCY 204
264 HYPOGLYCAEMIC COMA 202
265 RASH PRURITIC 202
266 SKIN EXFOLIATION 200
267 LIQUID PRODUCT PHYSICAL ISSUE 199
268 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 198
269 NEUTROPENIA 198
270 INFLUENZA LIKE ILLNESS 197
271 DYSPHONIA 196
272 BLOOD PHOSPHORUS INCREASED 195
273 OSTEOMYELITIS 194
274 ACCIDENTAL UNDERDOSE 192
275 HOT FLUSH 192
276 HYPERPARATHYROIDISM SECONDARY 191
277 CONVULSION 190
278 LACTIC ACIDOSIS 188
279 RECTAL HAEMORRHAGE 188
280 CORONARY ARTERY OCCLUSION 186
281 HYPOPHOSPHATAEMIA 186
282 SWELLING FACE 186
283 TOXICITY TO VARIOUS AGENTS 186
284 TYPE 2 DIABETES MELLITUS 186
285 PANCREATIC CARCINOMA 185
286 LIVER DISORDER 184
287 NECK PAIN 184
288 INSULIN RESISTANCE 182
289 RESPIRATORY SYMPTOM 182
290 DISORIENTATION 181
291 ACUTE MYOCARDIAL INFARCTION 179
292 ANGINA PECTORIS 179
293 BLOOD POTASSIUM INCREASED 179
294 FULL BLOOD COUNT ABNORMAL 179
295 HEAD INJURY 177
296 RHEUMATOID ARTHRITIS 177
297 WOUND 177
298 INJECTION SITE SWELLING 176
299 ACUTE RESPIRATORY FAILURE 175
300 INCORRECT DOSE ADMINISTERED BY DEVICE 175
301 LOWER RESPIRATORY TRACT INFECTION 175
302 DEVICE LEAKAGE 174
303 DISTURBANCE IN ATTENTION 174
304 UNRESPONSIVE TO STIMULI 172
305 ANAPHYLACTIC REACTION 171
306 DEPRESSED MOOD 171
307 GLAUCOMA 171
308 KETOACIDOSIS 171
309 MACULAR DEGENERATION 171
310 BLOOD URIC ACID INCREASED 169
311 DIALYSIS 169
312 ERUCTATION 169
313 METABOLIC ACIDOSIS 169
314 DYSARTHRIA 168
315 ARTHROPATHY 167
316 DISCOMFORT 167
317 HYPOPHAGIA 167
318 SPEECH DISORDER 167
319 ADVERSE DRUG REACTION 166
320 FIBROMYALGIA 166
321 OBSTRUCTIVE AIRWAYS DISORDER 166
322 TUBULOINTERSTITIAL NEPHRITIS 166
323 DRUG DISPENSING ERROR 165
324 JOINT INJURY 165
325 DRUG EFFECT DECREASED 164
326 DRY EYE 164
327 HERPES ZOSTER 164
328 HYPERPHOSPHATAEMIA 164
329 TINNITUS 164
330 ULCER 164
331 EXPOSURE DURING PREGNANCY 163
332 SEPTIC SHOCK 163
333 SUICIDAL IDEATION 161
334 PRODUCT DISPENSING ERROR 160
335 COMA 159
336 PANCREATITIS ACUTE 159
337 HEPATIC ENZYME INCREASED 158
338 DYSURIA 154
339 SKIN DISCOLOURATION 154
340 VASCULITIS 154
341 HYPERSOMNIA 153
342 HEPATIC CIRRHOSIS 152
343 HEPATIC STEATOSIS 152
344 THERAPY INTERRUPTED 152
345 GAIT INABILITY 151
346 INTESTINAL OBSTRUCTION 151
347 ARTERIOSCLEROSIS 150
348 HAEMATURIA 150
349 LIMB DISCOMFORT 150
350 PULMONARY VASCULITIS 150
351 CARPAL TUNNEL SYNDROME 149
352 PULMONARY ALVEOLAR HAEMORRHAGE 148
353 BONE PAIN 146
354 RHABDOMYOLYSIS 145
355 EXTRA DOSE ADMINISTERED 143
356 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 143
357 IRRITABILITY 141
358 KIDNEY INFECTION 141
359 HUNGER 140
360 MALIGNANT NEOPLASM PROGRESSION 140
361 NO ADVERSE EVENT 140
362 HYPOGLYCAEMIC SEIZURE 139
363 TROPONIN INCREASED 139
364 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 139
365 ARTERIOSCLEROSIS CORONARY ARTERY 138
366 FLUID OVERLOAD 138
367 HIP FRACTURE 138
368 INCREASED APPETITE 138
369 INTERVERTEBRAL DISC PROTRUSION 138
370 ADVERSE EVENT 137
371 DEVICE MECHANICAL ISSUE 137
372 INTERNATIONAL NORMALISED RATIO INCREASED 136
373 LOWER LIMB FRACTURE 136
374 THERAPY CESSATION 136
375 ANHEDONIA 135
376 PANCYTOPENIA 135
377 HAEMATOCHEZIA 134
378 NEURITIS 134
379 OSTEOPOROSIS 134
380 URINARY INCONTINENCE 134
381 IMPAIRED HEALING 133
382 NEUROLOGICAL SYMPTOM 133
383 ACCIDENTAL OVERDOSE 132
384 FOOT FRACTURE 132
385 TOE AMPUTATION 132
386 CARDIO-RESPIRATORY ARREST 131
387 DIABETIC FOOT 129
388 GASTRITIS 129
389 IRON DEFICIENCY 128
390 SUICIDE ATTEMPT 128
391 THERAPEUTIC RESPONSE UNEXPECTED 128
392 BREAST CANCER 127
393 INCORRECT PRODUCT STORAGE 127
394 NEPHROPATHY 127
395 UPPER LIMB FRACTURE 126
396 BLOOD UREA INCREASED 125
397 DYSSTASIA 125
398 THIRST 125
399 CATARACT OPERATION 124
400 ARRHYTHMIA 123
401 BACK DISORDER 123
402 RENAL TRANSPLANT 123
403 SWOLLEN TONGUE 123
404 TYPE 1 DIABETES MELLITUS 123
405 BLOOD CALCIUM INCREASED 122
406 CARDIAC OPERATION 122
407 DEVICE BREAKAGE 122
408 THERAPEUTIC RESPONSE DECREASED 122
409 VIRAL INFECTION 122
410 WRONG PRODUCT ADMINISTERED 122
411 ANALGESIC THERAPY 121
412 CARDIOVASCULAR DISORDER 121
413 EYE SWELLING 121
414 LACRIMATION INCREASED 121
415 ANKLE FRACTURE 120
416 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 120
417 INTENTIONAL DOSE OMISSION 120
418 INTENTIONAL OVERDOSE 120
419 LEUKOCYTOSIS 120
420 RENAL FAILURE CHRONIC 120
421 RESPIRATORY DISTRESS 120
422 SLEEP DISORDER THERAPY 119
423 EYE IRRITATION 118
424 PRURITUS GENERALISED 118
425 LEG AMPUTATION 117
426 MENTAL DISORDER 117
427 NODULE 117
428 PRESYNCOPE 117
429 WHITE BLOOD CELL COUNT INCREASED 117
430 CYSTIC FIBROSIS 116
431 REBOUND ACID HYPERSECRETION 116
432 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 115
433 DEAFNESS 115
434 DIABETIC COMA 115
435 RIB FRACTURE 115
436 BLOOD SODIUM DECREASED 114
437 DRUG THERAPY 114
438 COGNITIVE DISORDER 113
439 GASTROENTERITIS VIRAL 113
440 RALES 113
441 FEBRILE NEUTROPENIA 112
442 PHARMACEUTICAL PRODUCT COMPLAINT 112
443 FORCED EXPIRATORY VOLUME DECREASED 111
444 SKIN LESION 111
445 ANGIOEDEMA 110
446 MALNUTRITION 110
447 THROAT IRRITATION 110
448 AORTIC STENOSIS 109
449 HEART RATE DECREASED 109
450 HEART RATE IRREGULAR 109
451 PALLOR 109
452 CEREBRAL HAEMORRHAGE 108
453 DELIRIUM 108
454 FEMUR FRACTURE 108
455 LYMPHOEDEMA 108
456 OBESITY 108
457 BLOOD TEST ABNORMAL 107
458 ENCEPHALOPATHY 107
459 FEELING COLD 107
460 FLANK PAIN 107
461 INJECTION SITE REACTION 107
462 COLD SWEAT 106
463 FEEDING DISORDER 106
464 TOTAL LUNG CAPACITY ABNORMAL 106
465 COLITIS 105
466 DYSKINESIA 105
467 BLOOD PRESSURE ABNORMAL 104
468 ABORTION SPONTANEOUS 103
469 APHASIA 103
470 MENTAL IMPAIRMENT 103
471 PERICARDIAL EFFUSION 103
472 RASH ERYTHEMATOUS 103
473 RETCHING 103
474 URINARY RETENTION 103
475 ECONOMIC PROBLEM 102
476 GANGRENE 102
477 LIP SWELLING 102
478 RED BLOOD CELL COUNT DECREASED 102
479 WRONG TECHNIQUE IN DRUG USAGE PROCESS 102
480 PLASMA CELL MYELOMA 101
481 ACCIDENTAL EXPOSURE TO PRODUCT 100
482 ASPIRATION 100
483 BLOOD TRIGLYCERIDES INCREASED 100
484 NIGHT SWEATS 100
485 INJURY ASSOCIATED WITH DEVICE 99
486 PULMONARY HYPERTENSION 99
487 HAEMATEMESIS 98
488 ABASIA 97
489 LABORATORY TEST ABNORMAL 97
490 LIVER FUNCTION TEST INCREASED 97
491 RENAL TUBULAR NECROSIS 97
492 SKIN DISORDER 97
493 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 96
494 DEPRESSED LEVEL OF CONSCIOUSNESS 96
495 DIPLOPIA 96
496 DRUG PRESCRIBING ERROR 96
497 SCAR 96
498 STENT PLACEMENT 96
499 BLOOD ALKALINE PHOSPHATASE INCREASED 95
500 GLOMERULAR FILTRATION RATE DECREASED 95
501 PRODUCT SUBSTITUTION ISSUE 95
502 DIVERTICULITIS 94
503 HEPATIC FAILURE 94
504 GASTROINTESTINAL HYPOMOTILITY 93
505 MULTIPLE SCLEROSIS RELAPSE 93
506 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 92
507 NORMOCHROMIC NORMOCYTIC ANAEMIA 92
508 OCULAR HYPERAEMIA 92
509 RASH GENERALISED 92
510 RETINAL DETACHMENT 92
511 BLOOD CREATINE PHOSPHOKINASE INCREASED 91
512 FEELING JITTERY 91
513 HAEMATOCRIT DECREASED 91
514 PANCREATIC DISORDER 91
515 UPPER GASTROINTESTINAL HAEMORRHAGE 91
516 CRYING 90
517 PREMATURE BABY 90
518 GALLBLADDER DISORDER 89
519 INJECTION SITE NODULE 89
520 LUNG NEOPLASM MALIGNANT 89
521 POST PROCEDURAL COMPLICATION 89
522 RESTLESSNESS 89
523 TASTE DISORDER 89
524 FEAR 88
525 HAEMATOMA 88
526 NERVE INJURY 88
527 THYROID DISORDER 88
528 UROSEPSIS 88
529 CARDIOMEGALY 87
530 EATING DISORDER 87
531 PNEUMONIA ASPIRATION 87
532 PSORIATIC ARTHROPATHY 87
533 HAEMORRHOIDS 86
534 INJECTION SITE EXTRAVASATION 86
535 MOVEMENT DISORDER 86
536 PANIC ATTACK 86
537 PRODUCT DOSE OMISSION IN ERROR 86
538 RESPIRATORY DISORDER 86
539 DISEASE RECURRENCE 85
540 RESPIRATORY TRACT INFECTION 85
541 RETINOPATHY 85
542 BLOOD MAGNESIUM DECREASED 84
543 DECUBITUS ULCER 84
544 ORTHOSTATIC HYPOTENSION 84
545 RESTLESS LEGS SYNDROME 84
546 RETINAL HAEMORRHAGE 84
547 ROTATOR CUFF SYNDROME 84
548 ATELECTASIS 83
549 GASTRIC DISORDER 83
550 ILEUS 83
551 INFLAMMATION 83
552 MICTURITION URGENCY 83
553 PULMONARY MASS 83
554 EAR INFECTION 82
555 PRODUCT USE COMPLAINT 82
556 SINUS DISORDER 82
557 SPINAL FRACTURE 82
558 SPIROMETRY ABNORMAL 82
559 CLOSTRIDIUM DIFFICILE INFECTION 81
560 CONJUNCTIVITIS ALLERGIC 81
561 DRUG DOSE OMISSION BY DEVICE 81
562 GENERALISED OEDEMA 81
563 PAIN IN JAW 81
564 APPETITE DISORDER 80
565 BENIGN PROSTATIC HYPERPLASIA 80
566 DIABETIC NEPHROPATHY 80
567 EMOTIONAL DISORDER 80
568 JOINT STIFFNESS 80
569 KNEE ARTHROPLASTY 80
570 HYPERCHOLESTEROLAEMIA 79
571 LIVER FUNCTION TEST ABNORMAL 79
572 ANTACID THERAPY 78
573 DEVICE DELIVERY SYSTEM ISSUE 78
574 INTERSTITIAL LUNG DISEASE 78
575 SHOCK 78
576 ABSCESS 77
577 CEREBRAL INFARCTION 77
578 DIABETIC COMPLICATION 77
579 LYMPHADENOPATHY 77
580 SCIATICA 77
581 ANTICOAGULANT THERAPY 76
582 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 76
583 BONE DISORDER 76
584 IRON DEFICIENCY ANAEMIA 76
585 JAUNDICE 76
586 TRANSAMINASES INCREASED 76
587 FAECES DISCOLOURED 75
588 FOURNIER^S GANGRENE 75
589 HEPATIC FUNCTION ABNORMAL 75
590 HIATUS HERNIA 75
591 MUSCULOSKELETAL DISCOMFORT 75
592 PRODUCT PRESCRIBING ERROR 75
593 THROAT TIGHTNESS 75
594 ARTERIAL OCCLUSIVE DISEASE 74
595 BLOOD URINE PRESENT 74
596 COAGULOPATHY 74
597 HERNIA 74
598 INFUSION SITE PAIN 74
599 INJECTION SITE RASH 74
600 AGEUSIA 73
601 ANOREXIA 73
602 FULL BLOOD COUNT DECREASED 73
603 HYPOMAGNESAEMIA 73
604 OESOPHAGEAL SPASM 73
605 ABNORMAL BEHAVIOUR 72
606 COVID-19 PNEUMONIA 72
607 DUST ALLERGY 72
608 HEPATIC CYTOLYSIS 72
609 INFUSION RELATED REACTION 72
610 NEEDLE ISSUE 72
611 PANCREATIC CARCINOMA METASTATIC 72
612 PROSTATE CANCER 72
613 SKIN BURNING SENSATION 72
614 THINKING ABNORMAL 72
615 VAGINAL HAEMORRHAGE 72
616 BACTERAEMIA 71
617 SEASONAL ALLERGY 71
618 THERAPY NON-RESPONDER 71
619 CORONARY ARTERY BYPASS 70
620 HEMIPARESIS 70
621 INJECTION SITE URTICARIA 70
622 MITE ALLERGY 70
623 MYCOTIC ALLERGY 70
624 OESOPHAGEAL PAIN 70
625 AGGRESSION 69
626 COMPLETED SUICIDE 69
627 PREMATURE DELIVERY 69
628 SPINAL OPERATION 69
629 DEVICE DEFECTIVE 68
630 MITRAL VALVE INCOMPETENCE 68
631 NERVOUS SYSTEM DISORDER 68
632 PRODUCT PHYSICAL ISSUE 68
633 RASH MACULAR 68
634 THERAPEUTIC PRODUCT EFFECT DECREASED 68
635 ANGER 67
636 BREATH SOUNDS ABNORMAL 67
637 CHOLECYSTECTOMY 67
638 COLON CANCER 67
639 DEVICE OPERATIONAL ISSUE 67
640 HALLUCINATION, VISUAL 67
641 HYPOVOLAEMIA 67
642 LEUKOPENIA 67
643 LOCAL SWELLING 67
644 MOOD ALTERED 67
645 POOR QUALITY SLEEP 67
646 PRODUCT ODOUR ABNORMAL 67
647 CROHN^S DISEASE 66
648 GASTROENTERITIS 66
649 HAIR COLOUR CHANGES 66
650 HEPATIC ENCEPHALOPATHY 66
651 MOOD SWINGS 66
652 PROTEINURIA 66
653 RESPIRATION ABNORMAL 66
654 SYSTEMIC LUPUS ERYTHEMATOSUS 66
655 ACCIDENT 65
656 BLINDNESS TRANSIENT 65
657 BLOOD BILIRUBIN INCREASED 65
658 HOSPICE CARE 65
659 INTERNAL HAEMORRHAGE 65
660 ORAL PAIN 65
661 PRODUCT ADMINISTRATION ERROR 65
662 SMALL INTESTINAL OBSTRUCTION 65
663 ACNE 64
664 ATRIAL FLUTTER 64
665 CAESAREAN SECTION 64
666 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 64
667 DEVICE RELATED INFECTION 64
668 EYE PRURITUS 64
669 INJECTION SITE HAEMATOMA 64
670 MELAENA 64
671 NEUTROPHIL COUNT DECREASED 64
672 PARKINSON^S DISEASE 64
673 WOUND INFECTION 64
674 BLOOD PRESSURE FLUCTUATION 63
675 BLOOD PRESSURE SYSTOLIC INCREASED 63
676 EAR PAIN 63
677 HYPOTHERMIA 63
678 SPLENOMEGALY 63
679 VITAMIN D DEFICIENCY 63
680 ALTERED STATE OF CONSCIOUSNESS 62
681 DRUG ABUSE 62
682 EYE OPERATION 62
683 FREQUENT BOWEL MOVEMENTS 62
684 HYPOKINESIA 62
685 INCORRECT PRODUCT ADMINISTRATION DURATION 62
686 INJECTION SITE INDURATION 62
687 LACERATION 62
688 OSTEOPENIA 62
689 SKIN CANCER 62
690 TOOTH DISORDER 62
691 CHOLECYSTITIS 61
692 CHROMATURIA 61
693 DIZZINESS POSTURAL 61
694 INJECTION SITE DISCOLOURATION 61
695 INJECTION SITE IRRITATION 61
696 INTERVERTEBRAL DISC DEGENERATION 61
697 IRRITABLE BOWEL SYNDROME 61
698 MASS 61
699 PHOTOPHOBIA 61
700 POOR PERIPHERAL CIRCULATION 61
701 PYELONEPHRITIS 61
702 RESPIRATORY ARREST 61
703 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 60
704 DIABETIC METABOLIC DECOMPENSATION 60
705 GASTRIC ULCER 60
706 WEIGHT FLUCTUATION 60
707 WHEELCHAIR USER 60
708 CARDIOMYOPATHY 59
709 DRUG-INDUCED LIVER INJURY 59
710 PRODUCT COMMUNICATION ISSUE 59
711 TOOTHACHE 59
712 BLOOD IRON DECREASED 58
713 HYPOAESTHESIA ORAL 58
714 MUSCULOSKELETAL DISORDER 58
715 PERIPHERAL VASCULAR DISORDER 58
716 PROCEDURAL PAIN 58
717 SINUS CONGESTION 58
718 SPINAL OSTEOARTHRITIS 58
719 TOTAL LUNG CAPACITY DECREASED 58
720 ESCHERICHIA INFECTION 57
721 MULTIPLE SCLEROSIS 57
722 MUSCLE TWITCHING 57
723 MUSCULOSKELETAL CHEST PAIN 57
724 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57
725 RENAL CANCER 57
726 RESPIRATORY TRACT CONGESTION 57
727 BACK INJURY 56
728 DEVICE DIFFICULT TO USE 56
729 EXOSTOSIS 56
730 HAEMORRHAGIC ANAEMIA 56
731 MULTI-ORGAN FAILURE 56
732 MUSCLE TIGHTNESS 56
733 NERVE COMPRESSION 56
734 RENAL CYST 56
735 SEROTONIN SYNDROME 56
736 VENTRICULAR TACHYCARDIA 56
737 VITREOUS FLOATERS 56
738 ABSCESS LIMB 55
739 BODY TEMPERATURE INCREASED 55
740 BRAIN INJURY 55
741 CARDIAC MURMUR 55
742 CONGENITAL HIATUS HERNIA 55
743 CYST 55
744 DRUG EFFECT INCOMPLETE 55
745 GLOSSODYNIA 55
746 INSURANCE ISSUE 55
747 PULMONARY CONGESTION 55
748 CONCUSSION 54
749 ESSENTIAL HYPERTENSION 54
750 LUNG OPACITY 54
751 SINUS TACHYCARDIA 54
752 ABDOMINAL PAIN LOWER 53
753 CLOSTRIDIUM DIFFICILE COLITIS 53
754 CONTRAINDICATED PRODUCT ADMINISTERED 53
755 DEMENTIA ALZHEIMER^S TYPE 53
756 DEVICE USE ISSUE 53
757 ECZEMA 53
758 ELECTROLYTE IMBALANCE 53
759 HAIR TEXTURE ABNORMAL 53
760 HEPATIC CANCER 53
761 HYPOCALCAEMIA 53
762 INABILITY TO AFFORD MEDICATION 53
763 JOINT RANGE OF MOTION DECREASED 53
764 NECROTISING FASCIITIS 53
765 OBSTRUCTIVE SLEEP APNOEA SYNDROME 53
766 PLEURITIC PAIN 53
767 PNEUMOTHORAX 53
768 SPUTUM DISCOLOURED 53
769 WRIST FRACTURE 53
770 CHOKING 52
771 EJECTION FRACTION DECREASED 52
772 IMPAIRED QUALITY OF LIFE 52
773 INCORRECT DRUG ADMINISTRATION DURATION 52
774 INJECTION SITE INJURY 52
775 ISCHAEMIC STROKE 52
776 MALIGNANT MELANOMA STAGE 0 52
777 RASH PAPULAR 52
778 SKIN LACERATION 52
779 SNEEZING 52
780 ANAL INCONTINENCE 51
781 DRUG EXPOSURE DURING PREGNANCY 51
782 INCONTINENCE 51
783 KNEE OPERATION 51
784 LYMPHOMA 51
785 PRODUCT AVAILABILITY ISSUE 51
786 THERAPEUTIC PRODUCT EFFECT DELAYED 51
787 TOOTH INFECTION 51
788 ULTRASOUND ANTENATAL SCREEN 51
789 CORONARY ARTERIAL STENT INSERTION 50
790 DRUG LEVEL INCREASED 50
791 DRUG WITHDRAWAL SYNDROME 50
792 GLYCOSYLATED HAEMOGLOBIN DECREASED 50
793 INCOHERENT 50
794 LOWER GASTROINTESTINAL HAEMORRHAGE 50
795 METASTASES TO LIVER 50
796 MYOCARDIAL ISCHAEMIA 50
797 NOCTURIA 50
798 PARAESTHESIA ORAL 50
799 PERIPHERAL COLDNESS 50
800 PULMONARY THROMBOSIS 50
801 SKIN HAEMORRHAGE 50
802 TACHYPNOEA 50
803 WALKING AID USER 50
804 ACTIVITIES OF DAILY LIVING IMPAIRED 49
805 ACUTE RESPIRATORY DISTRESS SYNDROME 49
806 CAPILLARITIS 49
807 EUGLYCAEMIC DIABETIC KETOACIDOSIS 49
808 HYPERVOLAEMIA 49
809 LUNG INFILTRATION 49
810 PERITONITIS 49
811 PHARYNGEAL SWELLING 49
812 PSEUDOMONAS INFECTION 49
813 SKIN IRRITATION 49
814 TRIGGER FINGER 49
815 FOOT AMPUTATION 48
816 HEPATOMEGALY 48
817 MULTIPLE USE OF SINGLE-USE PRODUCT 48
818 PNEUMONITIS 48
819 PSYCHOLOGICAL TRAUMA 48
820 SKIN FISSURES 48
821 SLUGGISHNESS 48
822 URINE KETONE BODY PRESENT 48
823 ATRIOVENTRICULAR BLOCK 47
824 BONE DENSITY DECREASED 47
825 BRONCHIECTASIS 47
826 C-REACTIVE PROTEIN INCREASED 47
827 CYTOKINE RELEASE SYNDROME 47
828 DEPRESSIVE SYMPTOM 47
829 EYE INFECTION 47
830 VASCULAR GRAFT 47
831 ADENOCARCINOMA PANCREAS 46
832 BLOOD CALCIUM DECREASED 46
833 CANDIDA INFECTION 46
834 CORRECTIVE LENS USER 46
835 ERECTILE DYSFUNCTION 46
836 LUNG INFECTION 46
837 NIGHTMARE 46
838 OESOPHAGITIS 46
839 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 46
840 SUBDURAL HAEMATOMA 46
841 TOOTH LOSS 46
842 TREATMENT FAILURE 46
843 UPPER-AIRWAY COUGH SYNDROME 46
844 WOUND COMPLICATION 46
845 BRAIN FOG 45
846 CAROTID ARTERY OCCLUSION 45
847 CHOLESTASIS 45
848 COLITIS ULCERATIVE 45
849 HAIR DISORDER 45
850 HYPERKERATOSIS 45
851 MACULAR OEDEMA 45
852 PHARYNGEAL OEDEMA 45
853 POST PROCEDURAL HAEMORRHAGE 45
854 TRICUSPID VALVE INCOMPETENCE 45
855 BLADDER DISORDER 44
856 BLOOD COUNT ABNORMAL 44
857 ELECTROCARDIOGRAM QT PROLONGED 44
858 HAND FRACTURE 44
859 HEAD DISCOMFORT 44
860 HEPATITIS 44
861 IMMUNE SYSTEM DISORDER 44
862 IMPAIRED WORK ABILITY 44
863 PERITONITIS BACTERIAL 44
864 PROLONGED EXPIRATION 44
865 SUPRAVENTRICULAR TACHYCARDIA 44
866 AMMONIA INCREASED 43
867 CARDIAC PACEMAKER INSERTION 43
868 COELIAC DISEASE 43
869 DEVICE DISLOCATION 43
870 DRUG DEPENDENCE 43
871 EXPIRED DRUG ADMINISTERED 43
872 HEART SOUNDS 43
873 HYPERNATRAEMIA 43
874 MADAROSIS 43
875 MUSCLE ATROPHY 43
876 OVERWEIGHT 43
877 PARANOIA 43
878 PRESCRIBED OVERDOSE 43
879 SCAB 43
880 TENDERNESS 43
881 TRANSFUSION 43
882 VITAMIN D DECREASED 43
883 ARTHROPOD BITE 42
884 BACTEROIDES INFECTION 42
885 DECREASED ACTIVITY 42
886 ESCHERICHIA URINARY TRACT INFECTION 42
887 HYPERCALCAEMIA 42
888 INJECTION SITE DISCOMFORT 42
889 METABOLIC ENCEPHALOPATHY 42
890 MOUTH ULCERATION 42
891 MULTIPLE INJURIES 42
892 MUSCLE DISORDER 42
893 PRODUCT STORAGE ISSUE 42
894 SUBCUTANEOUS ABSCESS 42
895 THERAPEUTIC RESPONSE SHORTENED 42
896 WITHDRAWAL SYNDROME 42
897 ABNORMAL DREAMS 41
898 CIRCULATORY COLLAPSE 41
899 DIVERTICULUM INTESTINAL 41
900 FRUSTRATION TOLERANCE DECREASED 41
901 HAEMOLYTIC ANAEMIA 41
902 HAEMORRHAGIC STROKE 41
903 HICCUPS 41
904 HIP ARTHROPLASTY 41
905 HYDROPS FOETALIS 41
906 HYPERGLYCAEMIC UNCONSCIOUSNESS 41
907 IMPAIRED DRIVING ABILITY 41
908 LIGAMENT SPRAIN 41
909 PSYCHOTIC DISORDER 41
910 PULMONARY ARTERIAL HYPERTENSION 41
911 SINUS BRADYCARDIA 41
912 SKIN INFECTION 41
913 TARDIVE DYSKINESIA 41
914 URINE OUTPUT DECREASED 41
915 ABNORMAL LOSS OF WEIGHT 40
916 ACIDOSIS 40
917 BODY HEIGHT DECREASED 40
918 CARDIAC VALVE DISEASE 40
919 EARLY SATIETY 40
920 FAILURE TO THRIVE 40
921 GASTROINTESTINAL PAIN 40
922 KIDNEY TRANSPLANT REJECTION 40
923 LEFT VENTRICULAR HYPERTROPHY 40
924 ORAL DISCOMFORT 40
925 POLYP 40
926 AUTOIMMUNE DISORDER 39
927 BOWEL MOVEMENT IRREGULARITY 39
928 BURSITIS 39
929 CLEFT LIP AND PALATE 39
930 HAEMORRHAGE INTRACRANIAL 39
931 HYPOGLYCAEMIA NEONATAL 39
932 INTENTIONAL DEVICE MISUSE 39
933 LYMPHOCYTE COUNT DECREASED 39
934 MUSCLE STRAIN 39
935 MYOPATHY 39
936 OSTEONECROSIS OF JAW 39
937 PARALYSIS 39
938 SHOCK HYPOGLYCAEMIC 39
939 BEDRIDDEN 38
940 COORDINATION ABNORMAL 38
941 DIVERTICULUM 38
942 EMPHYSEMA 38
943 FURUNCLE 38
944 HYPERTHYROIDISM 38
945 LEFT VENTRICULAR DYSFUNCTION 38
946 LEUKAEMIA 38
947 METASTASES TO LUNG 38
948 MICROSPORIDIA INFECTION 38
949 NEOPLASM PROGRESSION 38
950 POSTOPERATIVE WOUND INFECTION 38
951 SHOCK HAEMORRHAGIC 38
952 TOOTH EXTRACTION 38
953 BIPOLAR DISORDER 37
954 BLOOD ALBUMIN DECREASED 37
955 CAROTID ARTERY STENOSIS 37
956 ELECTROCARDIOGRAM ABNORMAL 37
957 EPILEPSY 37
958 EXPOSURE VIA SKIN CONTACT 37
959 EYE DISCHARGE 37
960 FOETAL GROWTH RESTRICTION 37
961 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37
962 MENISCUS INJURY 37
963 METASTASES TO BONE 37
964 MIDDLE INSOMNIA 37
965 PRE-EXISTING CONDITION IMPROVED 37
966 PRODUCT TASTE ABNORMAL 37
967 PULSE ABSENT 37
968 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37
969 SARS-COV-2 TEST POSITIVE 37
970 SCRATCH 37
971 SECRETION DISCHARGE 37
972 TENDON RUPTURE 37
973 TOXIC EPIDERMAL NECROLYSIS 37
974 TRISOMY 18 37
975 VARICOSE VEIN 37
976 ANGINA UNSTABLE 36
977 BLOOD CREATINE INCREASED 36
978 DECREASED INTEREST 36
979 DERMATITIS ATOPIC 36
980 DYSLIPIDAEMIA 36
981 GOITRE 36
982 INCORRECT ROUTE OF DRUG ADMINISTRATION 36
983 NEUROPATHIC ARTHROPATHY 36
984 OSTEONECROSIS 36
985 PANCREATITIS CHRONIC 36
986 PHARYNGITIS 36
987 POLYURIA 36
988 PRODUCT PACKAGING QUANTITY ISSUE 36
989 SEDATION 36
990 SPINAL DISORDER 36
991 FRACTURE 35
992 IMMUNODEFICIENCY 35
993 LIPASE INCREASED 35
994 LIVER INJURY 35
995 NEOPLASM 35
996 NEUROTOXICITY 35
997 ORTHOPNOEA 35
998 PNEUMONIA BACTERIAL 35
999 POST PROCEDURAL INFECTION 35